Leuko
4 known investors
Find your way into Leuko
438 people in our graph share verified history with the Leuko team — schools, employers, funds. One of them is your warm intro.
Noubar Afeyanunlockedknows Carlos Castro Gonzalez · together at Massachusetts Institute of Technology (MIT) (overlapped)
×8knows the team · via Massachusetts Institute of Technology (MIT)
×3knows the team · via Centre National de la Recherche Scientifique (CNRS)
Leuko develops PointCheck, a noninvasive finger-based device that measures white blood cell levels using light imaging and AI to assess infection risk in cancer patients. The platform is designed for at-home monitoring and supports clinical care decisions for immunocompromised populations.
Founders & leadership
CC
Carlos Castro-GonzalezinFounderCarlos Castro-Gonzalez holds a PhD in Biomedical Engineering from Technical University of Madrid and completed a postdoctoral fellowship at MIT leading medical imaging research. He founded Leuko, an MIT spinout, and has prior experience developing AI algorithms for cardiac imaging and ultrasound diagnostics for clinical applications.
Investors · 4
Nina CapitalBarcelona · $215K – $1.6M
Good Growth CapitalreportedCharleston
IAG Capital PartnersreportedCharleston
Also in the syndicate · 1
HTH VC
Funding
SEC filings, press & company announcements$5M disclosed across 1 of 2 rounds · 2022
- Undisclosed amountSeries AOct 2022Source ↗
- $5MSeries ASep 2022 · 4 sources
Good Growth Capital, HTH VC, IAG Capital Partners, Nina Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
The Leuko mafia →7 people who came through Leuko went on to found or lead other companies.
Marta G. ZanchiBoard DirectorFounded Nina Capital +1Amy SalzhauerBoard MemberFounded Good Growth CapitalCarlos Castro GonzalezFounderFounded Leuko LabsAurelien BourquardChief Data Scientist & CofounderFounded Leuko LabsAlvaro Sanchez-FerroCofounder | Chief Medical OfficerFounded Leuko LabsAmy SalzhauerBoard MemberFounded Good Growth CapitalAmy SalzhauerBoard MemberFounded Good Growth Capital
In the news
Frequently asked questions
- What does Leuko do?
- Leuko develops PointCheck, a noninvasive finger-based device that measures white blood cell levels using light imaging and AI to assess infection risk in cancer patients. The platform is designed for at-home monitoring and supports clinical care decisions for immunocompromised populations.
- Who founded Leuko?
- Leuko was founded by Carlos Castro-Gonzalez.
- Who are Leuko's investors?
- Leuko's investors include Nina Capital, Good Growth Capital, IAG Capital Partners.
- How much funding has Leuko raised?
- Leuko has disclosed $5M raised across 1 of its 2 known rounds.